Investigating how sugary and artificially sweetened beverages affect diabetes risk factors
Official title: Proteomic and integrative omic profiles of sugar- and artificially sweetened beverage consumption and changes in type 2 diabetes risk factors
Funded at Brigham and Women's Hospital · NIH-10910142 · Data updated 2026-11-12
This study is looking at how drinking sugary and artificially sweetened drinks might affect your risk of developing type 2 diabetes, and it aims to help people understand how their beverage choices can impact their health.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $158,220 |
| NIH project number | 5K01DK136968-02 |
| Project ID | NIH-10910142 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults who consume sugar-sweetened or artificially sweetened beverages and are at risk for type 2 diabetes.
✕Less likely to help
Patients who do not consume these types of beverages or who have already been diagnosed with type 2 diabetes may not benefit from this research.
What this research studies
This research explores the relationship between the consumption of sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) and the risk factors associated with type 2 diabetes (T2D). By analyzing blood samples for proteomic and multi-omic profiles, the study aims to identify biological markers that reflect dietary intake and its impact on metabolic health. The goal is to enhance dietary assessment methods and provide insights into how these beverages influence diabetes risk, ultimately helping individuals make informed dietary choices.
Why it matters
Potential benefit: If successful, this research could lead to better dietary guidelines and personalized nutrition strategies that reduce the risk of type 2 diabetes.
How similar studies have gone: Previous research has shown promising results in using proteomic profiling to understand dietary impacts on health, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Haslam, Danielle — Brigham and Women's Hospital
- Study coordinator: Haslam, Danielle
Related research
Other NIH-funded projects on the same topics.
-
Why some teens develop type 2 diabetes
This project looks at how puberty, obesity, and social or behavioral factors may cause some adolescents to develop type 2 diabetes.
-
Using a very low-carbohydrate diet to lower diabetes risk
This study is looking at whether a very low-carb diet can help people at risk for type 2 diabetes do better in a program designed to prevent the disease, and it’s for adults who want to improve their blood sugar levels and overall health.
-
Investigating the impact of PFAS on kidney disease in young people with type 2 diabetes
This study is looking at how certain chemicals called PFAS might affect kidney health in young people with type 2 diabetes, helping to find out who might be at risk for kidney problems and how these chemicals could be involved.
-
Investigating the impact of fat around the heart on diabetes and heart health in young people undergoing weight loss surgery
This study is looking at how the fat around the heart affects heart health in teenagers with type 2 diabetes who are having weight loss surgery, using special heart scans to find out more about it and see how different diabetes treatments might help.
-
Identifying risk factors for type 2 diabetes in adolescents
This study is looking at what causes type 2 diabetes in kids aged 9 to 13, especially those who are overweight, to help figure out who might be at risk and how to prevent it.
-
Subtyping Core for Research on the Causes of Type 2 Diabetes (SCORE-T2D)
A new U01 grant from a university research team aims to understand why Type 2 diabetes differs so much between people and how to tailor prevention and treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.